Search Results - "LE MEUR, Yannick"

Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease by Porath, Binu, Gainullin, Vladimir G., Cornec-Le Gall, Emilie, Dillinger, Elizabeth K., Heyer, Christina M., Hopp, Katharina, Edwards, Marie E., Madsen, Charles D., Mauritz, Sarah R., Banks, Carly J., Baheti, Saurabh, Reddy, Bharathi, Herrero, José Ignacio, Bañales, Jesús M., Hogan, Marie C., Tasic, Velibor, Watnick, Terry J., Chapman, Arlene B., Vigneau, Cécile, Lavainne, Frédéric, Audrézet, Marie-Pierre, Ferec, Claude, Le Meur, Yannick, Torres, Vicente E., Harris, Peter C.

“…Autosomal-dominant polycystic kidney disease (ADPKD) is a common, progressive, adult-onset disease that is an important cause of end-stage renal disease…”
Get full text

Genetics and Pathogenesis of Autosomal Dominant Polycystic Kidney Disease: 20 Years On by Cornec-Le Gall, Emilie, Audrézet, Marie-Pierre, Le Meur, Yannick, Chen, Jian-Min, Férec, Claude

“…ABSTRACT Autosomal dominant polycystic kidney disease (ADPKD), the most common inherited kidney disorder, is characterized by the progressive development and…”
Get full text

Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation by Kuypers, Dirk R J, Le Meur, Yannick, Cantarovich, Marcelo, Tredger, Michael J, Tett, Susan E, Cattaneo, Dario, Tönshoff, Burkhard, Holt, David W, Chapman, Jeremy, Gelder, Teun van

“…With the increasing use of mycophenolic acid (MPA) in solid organ transplantation, the need for more accurate drug dosing has become evident. Personalized…”
Get full text

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation : Report of the European Consensus Conference by WALLEMACQ, Pierre, ARMSTRONG, Victor W, THERVET, Eric, TOENSHOFF, Burkhand, UNDRE, Nas, WEBER, Lutz T, WESTLEY, Ian S, MOURAD, Michel, BRUNET, Merce, HAUFROID, Vincent, HOLT, David W, JOHNSTON, Atholl, KUYPERS, Dirk, LE MEUR, Yannick, MARQUET, Pierre, OELLERICH, Michael

“…In 2007, a consortium of European experts on tacrolimus (TAC) met to discuss the most recent advances in the drug/dose optimization of TAC taking into account…”
Get full text

Selection of Pneumocystis jirovecii Inosine 5′-Monophosphate Dehydrogenase Mutants in Solid Organ Transplant Recipients: Implication of Mycophenolic Acid by Hoffmann, Claire V., Nevez, Gilles, Moal, Marie-Christine, Quinio, Dorothée, Le Nan, Nathan, Papon, Nicolas, Bouchara, Jean-Philippe, Le Meur, Yannick, Le Gal, Solène

“…Mycophenolic acid (MPA) targets the inosine 5′-monophosphate dehydrogenase (IMPDH) of human lymphocytes. It is widely used as an immunosuppressant to prevent…”
Get full text

Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods by Prémaud, Aurélie, Le Meur, Yannick, Debord, Jean, Szelag, Jean-Christophe, Rousseau, Annick, Hoizey, Guillaume, Toupance, Olivier, Marquet, Pierre

“…The aim of this study was to develop maximum a posteriori probability (MAP) Bayesian estimators of mycophenolic acid (MPA) pharmacokinetics (PK) capable of…”
Get full text

Mutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease by Porath, Binu, Gainullin, Vladimir G, Gall, Emilie Cornec-Le, Dillinger, Elizabeth K, Heyer, Christina M, Hopp, Katharina, Edwards, Marie E, Madsen, Charles D, Mauritz, Sarah R, Banks, Carly J, Baheti, Saurabh, Reddy, Bharathi, Herrero, José Ignacio, Bañales, Jesús M, Hogan, Marie C, Tasic, Velibor, Watnick, Terry J, Chapman, Arlene B, Vigneau, Cécile, Lavainne, Frédéric, Audrézet, Marie-Pierre, Ferec, Claude, Meur, Yannick Le, Torres, Vicente E, Group, Genkyst Study, Harris, Peter C

“…Autosomal-dominant polycystic kidney disease (ADPKD) is a common, progressive, adult-onset disease that is an important cause of end-stage renal disease…”
Get full text

Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring by Prémaud, Aurélie, Rousseau, Annick, Le Meur, Yannick, Lachâtre, Gérard, Marquet, Pierre

“…Mycophenolic acid (MPA) is an immunosuppressive drug partly metabolized to MPA-glucuronide (MPAG), which is pharmacologically inactive. The currently available…”
Get full text

Type of PKD1 Mutation Influences Renal Outcome in ADPKD by LE GALL, Emilie Cornec, AUDREZET, Marie-Pierre, GUILLODO, Marie-Paule, GRALL-JEZEQUEL, Anne, SALIOU, Philippe, FEREC, Claude, LE MEUR, Yannick, CHEN, Jian-Min, HOURMANT, Maryvonne, MORIN, Marie-Pascale, PERRICHOT, Régine, CHARASSE, Christophe, WHEBE, Bassem, RENAUDINEAU, Eric, JOUSSET, Philippe

“…Autosomal dominant polycystic kidney disease (ADPKD) is heterogeneous with regard to genic and allelic heterogeneity, as well as phenotypic variability. The…”
Get full text

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice by Gansevoort, Ron T, Arici, Mustafa, Benzing, Thomas, Birn, Henrik, Capasso, Giovambattista, Covic, Adrian, Devuyst, Olivier, Drechsler, Christiane, Eckardt, Kai-Uwe, Emma, Francesco, Knebelmann, Bertrand, Le Meur, Yannick, Massy, Ziad A, Ong, Albert C M, Ortiz, Alberto, Schaefer, Franz, Torra, Roser, Vanholder, Raymond, Więcek, Andrzej, Zoccali, Carmine, Van Biesen, Wim

“…Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst development and…”
Get full text

First‐in‐human use of a marine oxygen carrier (M101) for organ preservation: A safety and proof‐of‐principle study by Le Meur, Yannick, Badet, Lionel, Essig, Marie, Thierry, Antoine, Büchler, Matthias, Drouin, Sarah, Deruelle, Charles, Morelon, Emmanuel, Pesteil, Francis, Delpech, Pierre‐Olivier, Boutin, Jean‐Michel, Renard, Felix, Barrou, Benoit

“…The medical device M101 is an extracellular hemoglobin featuring high oxygen‐carrying capabilities. Preclinical studies demonstrated its safety as an additive…”
Get full text

REPRISE: tolvaptan in advanced polycystic kidney disease by Wyatt, Christina M, Le Meur, Yannick

Get more information

HEMO2life® improves renal function independent of cold ischemia time in kidney recipients: A comparison with a large multicenter prospective cohort study by Le Meur, Yannick, Delpy, Eric, Renard, Felix, Hauet, Thierry, Badet, Lionel, Rerolle, Jean Philippe, Thierry, Antoine, Büchler, Matthias, Zal, Franck, Barrou, Benoit

“…Background M101 is an extracellular hemoglobin isolated from a marine lugworm and is present in the medical device HEMO2life®. The clinical investigation OXYOP…”
Get full text

Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open‐label, multicenter phase 4 trial by Kaminski, Hannah, Kamar, Nassim, Thaunat, Olivier, Bouvier, Nicolas, Caillard, Sophie, Garrigue, Isabelle, Anglicheau, Dany, Rérolle, Jean‐Philippe, Le Meur, Yannick, Durrbach, Antoine, Bachelet, Thomas, Savel, Hélène, Coueron, Roxane, Visentin, Jonathan, Del Bello, Arnaud, Pellegrin, Isabelle, Déchanet‐Merville, Julie, Merville, Pierre, Thiébaut, Rodolphe, Couzi, Lionel

“…Cytomegalovirus (CMV) persists as the most frequent opportunistic infection among solid organ transplant recipients. This multicenter trial aimed to test…”
Get full text

Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19 by Boland, Lidvine, Devresse, Arnaud, Monchaud, Caroline, Briol, Sébastien, Belaiche, Stéphanie, Giguet, Baptiste, Couzi, Lionel, Thaunat, Olivier, Esposito, Laure, Meszaros, Magdalena, Roussoulieres, Ana, Haufroid, Vincent, Le Meur, Yannick, Lemaitre, Florian

“…Nirmatrelvir/ritonavir is a promising option for preventing severe COVID-19 in solid organ transplant recipients with SARS-CoV-2 infection. However, concerns…”
Get full text

Among CMV‐positive renal transplant patients receiving non‐T‐cell depleting induction, the absence of CMV disease prevention is a safe strategy: A retrospective cohort of 372 patients by Boulay, Hugoline, Oger, Emmanuel, Cantarovich, Diego, Gatault, Philippe, Thierry, Antoine, Le Meur, Yannick, Duveau, Agnès, Vigneau, Cécile, Lorcy, Nolwenn

“…Cytomegalovirus (CMV) is the most common opportunistic pathogen affecting renal transplant recipients, especially in the first months. CMV‐seropositive renal…”
Get full text

Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study by Giral, Magali, Grimbert, Philippe, Morin, Baptiste, Bouvier, Nicolas, Buchler, Matthias, Dantal, Jacques, Garrigue, Valérie, Bertrand, Dominique, Kamar, Nassim, Malvezzi, Paolo, Moreau, Karine, Athea, Yoni, Le Meur, Yannick

“…Once-daily extended-release tacrolimus (LCPT) exhibits increased bioavailability versus immediate-release (IR-TAC) and prolonged release (PR-TAC) tacrolimus…”
Get full text

Correction of Postkidney Transplant Anemia Reduces Progression of Allograft Nephropathy by CHOUKROUN, Gabriel, KAMAR, Nassim, JAUREGUY, Maïté, PALLET, Nicolas, LE MEUR, Yannick, ROSTAING, Lionel, MARTINEZ, Frank, DUSSOL, Bertrand, ETIENNE, Isabelle, CASSUTO-VIGUIER, Elisabeth, TOUPANCE, Olivier, GLOWACKI, François, MOULIN, Bruno, LEBRANCHU, Yvon, TOUCHARD, Guy

“…Retrospective studies suggest that chronic allograft nephropathy might progress more rapidly in patients with post-transplant anemia, but whether correction of…”
Get full text

Vitamin K antagonist has a higher impact than heparin in preventing circuit clotting in chronic haemodialysis patients by Charles, Pierre-Yves, Le Meur, Yannick, Tanquerel, Tugdual, Galinat, Hubert

“…In dialysis sessions, some data suggest that decreasing or even avoiding additional anticoagulation by heparin is possible among patients already treated with…”
Get full text

Adult-Onset Eculizumab-Resistant Hemolytic Uremic Syndrome Associated With Cobalamin C Deficiency by Cornec-Le Gall, Emilie, MD, Delmas, Yahsou, MD, PhD, De Parscau, Loïc, MD, Doucet, Laurent, MD, Ogier, Hélène, MD, Benoist, Jean-François, PhD, Fremeaux-Bacchi, Véronique, MD, PhD, Le Meur, Yannick, MD, PhD

“…A 20-year-old man was hospitalized for malignant hypertension, mechanical hemolysis, and kidney failure. Kidney biopsy confirmed glomerular and arteriolar…”
Get full text